Biography
Fan Xiulian, the CEO of Haisco Pharmaceutical Group, is a prominent figure in the healthcare industry, with an estimated net worth of $2 billion as of March 24, 2026. Her wealth stems from her success in the pharmaceuticals sector. Fan, along with partners, acquired the predecessor to Haisco in 2007 and took the company public in 2012. Haisco Pharmaceutical Group is known for its specialty pharmaceuticals, including those for anesthesia, oncology antiemetics, digestive care, antibiotics, and cardiovascular treatments. Fan Xiulian's leadership has been instrumental in the company's growth and its contribution to the pharmaceutical landscape.